The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Malignant Disease and Cardiovascular Morbidity in Hypopituitary Adults with or without Growth Hormone Replacement Therapy
Abstract
A retrospective comparison was performed between 1411 hypopituitary adults without GH replacement [mean age, 56.9 (sd 18.6) yr] and the normal population in terms of fatal and nonfatal morbidity. A similar prospective comparison was then made in 289 hypopituitary patients on long-term GH replacement [mean age, 47.6 (sd 14.8) yr; mean duration of GH treatment, 60 months]. In the 1411 hypopituitary patients without GH replacement, overall mortality (P < 0.001), and the rates of myocardial infarctions (P < 0.01), cerebrovascular events (P < 0.001), and malignancies (P < 0.001) were increased compared with the normal population. Colorectal cancer was the most common malignancy in this cohort (P < 0.001 vs. the background population). In the 289 hypopituitary patients on GH replacement, overall mortality and the rate of malignancies were similar to the normal population. In the hypopituitary adults on GH therapy, the rate of myocardial infarctions was lower than that in the background population (P < 0.05), and there was a tendency toward an increased rate of cerebrovascular events. In conclusion, overall mortality and the rate of myocardial infarctions were increased in hypopituitary patients without GH replacement. An increased rate of malignancies was observed in the hypopituitary adults without GH therapy, with a predominance of colorectal cancer. GH replacement appeared to provide protection from myocardial infarctions. The rate of cerebrovascular events tended to be increased also in hypopituitary adults on GH therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Self-citationIncreased mortality associated with growth hormone treatment in critically ill adults
Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411102 · Cited by 1,023
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822 · cited 6×
“3310 J Clin Endocrinol Metab, July 2004, 89(7):3306–3312 Svensson et al.”
BackgroundInfluentialSelf-citationIncreased cerebrovascular mortality in patients with hypopituitarism
Bülow, B., Hagmar, L., Mikoczy, Z., Nordström, C., & Erfurth, E. M. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1749.x · Cited by 542
The effect of hypopituitarism on life expectancy.
Bates, A. S., Van't Hoff, W., Jones, P. J., & Clayton, R. N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772595 · Cited by 475 · cited 1×
“studies (1, 3), whereas an increased rate of malignancies was”
BackgroundMarkussis, V., Beshyah, S. A., Johnston, D. G., Fisher, C., Nicolaides, A. N., & Sharp, P. (1992) · The Lancet · doi:10.1016/0140-6736(92)92892-j · Cited by 390
Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain
Regal, M., Páramo, C., Sierra, J. M., & García‐Mayor, R. V. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01406.x · Cited by 354 · cited 1×
“hypopituitarism was similar to that estimated in Spain in 1992 (27), the total number of hypopituitary adults in Sweden would be 2500.”
Result
Cited by
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Lipshultz, S. E., Adams, M. J., Colan, S. D., Constine, L. S., Herman, E. H., Hsu, D. T., Hudson, M. M., Kremer, L. C., Landy, D. C., Miller, T. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182a88099 · Cited by 612
Glucocorticoids and cardiovascular disease
Walker, B. R. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0455 · Cited by 529
Premature Mortality in Patients with Addison’s Disease: A Population-Based Study
Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0076 · Cited by 490
“We evaluated all patients hospitalized in Swedish hospitals for primary adrenal insufficiency between 1987–2001 using a technique similar to that described previously (16, 17).”
MethodSelf-citationMortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
Gurney, J. G., Ness, K. K., Sibley, S. D., O'Leary, M., Dengel, D. R., Lee, J. M., Youngren, N. M., Glasser, S. P., & Baker, K. S. (2006) · Cancer · doi:10.1002/cncr.22120 · Cited by 312
Yuen, K. C. J., Biller, B. M. K., Radovick, S., Carmichael, J. D., Jasim, S., Pantalone, K. M., & Hoffman, A. R. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0405 · Cited by 298
Burman, P., Mattsson, A. F., Johannsson, G., Höybye, C., Holmer, H., Dahlqvist, P., Berinder, K., Engström, B. E., Ekman, B., Erfurth, E. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4059 · Cited by 184
“Most previous studies have investigated deaths that occurred before 1987–1994 (2, 3, 5, 9), or before 2000–2001 (4, 10).”
Self-citationWilkinson, C. W., Pagulayan, K. F., Petrie, E. C., Mayer, C. L., Colasurdo, E. A., Shofer, J. B., Hart, K. L., Hoff, D., Tarabochia, M. A., & Peskind, E. R. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00011 · Cited by 162
Cancer risks in patients treated with growth hormone in childhood: the SAGhE European cohort study
Swerdlow, A. J., Cooke, R., Beckers, D., Borgström, B., Butler, G., Carel, J.-C., Cianfarani, S., Clayton, P., Coste, J., Deodati, A., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2046 · Cited by 153
Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies
Pappachan, J. M., Raskauskiene, D., Kutty, V. R., & Clayton, R. N. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3787 · Cited by 138
Growth Hormone and Cardiovascular Risk Factors
Gola, M., Bonadonna, S., Doga, M., & Giustina, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0545 · Cited by 135
Hormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones?
Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M., & Sonksen, P. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1002 · Cited by 132
Aguiar-Oliveira, M. H., Oliveira, F. T., Pereira, R. M. C., Oliveira, C. R. P., Blackford, A., Valenca, E. H. O., Santos, E. G., Gois-Junior, M. B., Meneguz-Moreno, R. A., Araujo, V. P., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1879 · Cited by 118
Mortality in adults with hypopituitarism: a systematic review and meta-analysis
Jasim, S., Alahdab, F., Ahmed, A. T., Tamhane, S., Prokop, L. J., Nippoldt, T. B., & Murad, M. H. (2017) · Endocrine · doi:10.1007/s12020-016-1159-3 · Cited by 112
Increased mortality risk in patients with primary and secondary adrenal insufficiency
Ngaosuwan, K., Johnston, D. G., Godsland, I. F., Cox, J., Majeed, A., Quint, J. K., Oliver, N., & Robinson, S. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab096 · Cited by 77
Yuen, K. C. J., Tritos, N. A., Samson, S. L., Hoffman, A. R., & Katznelson, L. (2016) · Endocrine Practice · doi:10.4158/ep161407.dscr · Cited by 73
Verhelst, J., Mattsson, A. F., Luger, A., Thunander, M., Góth, M. I., Kołtowska-Häggström, M., & Abs, R. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0599 · Cited by 71
Cardiovascular risk factors in hypopituitary GH-deficient adults
Verhelst, J., & Abs, R. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0291 · Cited by 70
GH deficiency as the most common pituitary defect after TBI: clinical implications
Popovic, V. (2005) · Pituitary · doi:10.1007/s11102-006-6047-z · Cited by 68
Ntali, G., Capatina, C., Fazal-Sanderson, V., Byrne, J. V., Cudlip, S., Grossman, A. B., Wass, J. A. H., & Karavitaki, N. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0967 · Cited by 64
Child, C. J., Conroy, D., Zimmermann, A. G., Woodmansee, W. W., Erfurth, E. M., & Robison, L. L. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1123 · Cited by 58
Petersons, C. J., Mangelsdorf, B. L., Thompson, C. H., & Burt, M. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4305 · Cited by 54
Filipsson, H., & Johannsson, G. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0319 · Cited by 50
Self-citationMorbidity and GH deficiency: a nationwide study.
Stochholm, K., Laursen, T., Green, A., Laurberg, P., Andersen, M., Kristensen, L. Ø., Feldt-Rasmussen, U., Christiansen, J. S., Frydenberg, M., & Gravholt, C. H. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0523 · Cited by 44
Nonalcoholic fatty liver disease and metabolic syndrome in hypopituitary patients
Nyenwe, E. A., Williamson-Baddorf, S., Waters, B., Wan, J. Y., & Solomon, S. S. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181a84bde · Cited by 28
Clinical predictors of GH deficiency in surgically cured acromegalic patients
Ku, C. R., Hong, J. W., Kim, E. H., Kim, S. H., & Lee, E. J. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0304 · Cited by 24
Metadata
- Authors
- Svensson, J., Bengtsson, B.-Å., Rosén, T., Odén, A., & Johannsson, G.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-07
- Volume
- 89
- Issue
- 7
- Pages
- 3306-3312
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2139394239
- Cited by
- 237
- References
- 7
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.